205 related articles for article (PubMed ID: 19421172)
1. High burden of late effects after haematopoietic stem cell transplantation in childhood: a single-centre study.
Bresters D; van Gils IC; Kollen WJ; Ball LM; Oostdijk W; van der Bom JG; Egeler RM
Bone Marrow Transplant; 2010 Jan; 45(1):79-85. PubMed ID: 19421172
[TBL] [Abstract][Full Text] [Related]
2. Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties.
Uderzo C; Pillon M; Corti P; Tridello G; Tana F; Zintl F; Nysom K; Galambrun C; Fagioli F; Varotto S; Messina C; Verdeguer A; Urban C; Faraci M; Dini G; Fedeli S; Tichelli A; Rovelli A; Socié G
Bone Marrow Transplant; 2007 Jun; 39(11):667-75. PubMed ID: 17401396
[TBL] [Abstract][Full Text] [Related]
3. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G;
Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401
[TBL] [Abstract][Full Text] [Related]
4. Visual, auditory, sensory, and motor impairments in long-term survivors of hematopoietic stem cell transplantation performed in childhood: results from the Bone Marrow Transplant Survivor study.
Gurney JG; Ness KK; Rosenthal J; Forman SJ; Bhatia S; Baker KS
Cancer; 2006 Mar; 106(6):1402-8. PubMed ID: 16453335
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
[TBL] [Abstract][Full Text] [Related]
6. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
[TBL] [Abstract][Full Text] [Related]
7. Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study.
Cohen A; Rovelli A; Merlo DF; van Lint MT; Lanino E; Bresters D; Ceppi M; Bocchini V; Tichelli A; Socié G
J Clin Oncol; 2007 Jun; 25(17):2449-54. PubMed ID: 17557958
[TBL] [Abstract][Full Text] [Related]
8. The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantation.
Delgado J; Cooper N; Thomson K; Duarte R; Jarmulowicz M; Cassoni A; Kottaridis P; Peggs K; Mackinnon S
Biol Blood Marrow Transplant; 2006 Jan; 12(1):75-83. PubMed ID: 16399571
[TBL] [Abstract][Full Text] [Related]
9. Severity of health conditions identified in a pediatric cancer survivor program.
Wasilewski-Masker K; Mertens AC; Patterson B; Meacham LR
Pediatr Blood Cancer; 2010 Jul; 54(7):976-82. PubMed ID: 20108334
[TBL] [Abstract][Full Text] [Related]
10. Abnormal liver enzymes two years after haematopoietic stem cell transplantation in children: prevalence and risk factors.
Bresters D; Van Gils IC; Dekker FW; Lankester AC; Bredius RG; Schweizer JJ
Bone Marrow Transplant; 2008 Jan; 41(1):27-31. PubMed ID: 17994124
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
[TBL] [Abstract][Full Text] [Related]
12. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
[TBL] [Abstract][Full Text] [Related]
13. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation.
Abboud I; Porcher R; Robin M; de Latour RP; Glotz D; Socié G; Peraldi MN
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1251-7. PubMed ID: 19747632
[TBL] [Abstract][Full Text] [Related]
14. Iron overload in survivors of childhood leukemia after allogeneic hematopoietic stem cell transplantation.
Chotsampancharoen T; Gan K; Kasow KA; Barfield RC; Hale GA; Leung W
Pediatr Transplant; 2009 May; 13(3):348-52. PubMed ID: 18518909
[TBL] [Abstract][Full Text] [Related]
15. Performance limitations and participation restrictions among childhood cancer survivors treated with hematopoietic stem cell transplantation: the bone marrow transplant survivor study.
Ness KK; Bhatia S; Baker KS; Francisco L; Carter A; Forman SJ; Robison LL; Rosenthal J; Gurney JG
Arch Pediatr Adolesc Med; 2005 Aug; 159(8):706-13. PubMed ID: 16061776
[TBL] [Abstract][Full Text] [Related]
16. Time-course and risk factors of hypothyroidism following allogeneic hematopoietic stem cell transplantation (HSCT) in children conditioned with fractionated total body irradiation.
Bailey HK; Kappy MS; Giller RH; Gralla J
Pediatr Blood Cancer; 2008 Sep; 51(3):405-9. PubMed ID: 18523993
[TBL] [Abstract][Full Text] [Related]
17. Endocrinological late complications after hematopoietic SCT in children.
Cohen A; Békássy AN; Gaiero A; Faraci M; Zecca S; Tichelli A; Dini G;
Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S43-8. PubMed ID: 18545244
[TBL] [Abstract][Full Text] [Related]
18. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
Gil L; Styczynski J; Komarnicki M
Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
[TBL] [Abstract][Full Text] [Related]
19. Incidence, etiology, and risk factors for liver dysfunction in children following hematopoietic stem cell transplantation.
Subbarao G; Haut PR; Johnson CS; Gowan D; Molleston JP
Pediatr Transplant; 2006 Sep; 10(6):682-9. PubMed ID: 16911491
[TBL] [Abstract][Full Text] [Related]
20. Endocrine complications of hematopoietic stem cell transplantation.
Chemaitilly W; Sklar CA
Endocrinol Metab Clin North Am; 2007 Dec; 36(4):983-98; ix. PubMed ID: 17983932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
